Stocks
Amicus Therapeutics, Inc.FOLD
NASDAQHealthcareBiotechnology$14.37+0.00%
Focused on therapies for rare metabolic diseases, the company develops and commercializes treatments targeting lysosomal storage disorders such as Fabry and Pompe disease. Its lead products include Galafold, an oral therapy for Fabry disease, and the Pompe disease combination therapy Pombiliti and O...
Market Cap: $4.5B52W Range: $5.51 – $14.39
Congressional Interest in Amicus Therapeutics, Inc. (FOLD)
1 member of Congress has disclosed 1 trade in Amicus Therapeutics, Inc. (FOLD), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading FOLD?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-04-10 | Daniel Goldman | sell | $1K – $15K |